בוטוקס 50 ישראל - עברית - Ministry of Health

בוטוקס 50

abbvie biopharmaceuticals ltd, israel - botulinum toxin type a - אבקה להכנת תמיסה לזריקה - botulinum toxin type a 50 u/vial - botulinum toxin - botulinum toxin - botox is indicated for the symptomatic relief of blepharospasm or vii nerve disorders in patients over 12 years hemifacial spasm and associated focal dystonias as well as the correction of strabismus in patients 12 years of age and above. botox is also indicated for the reduction of the signs and symptoms of spasmodic torticollis ( cervical dystonia) in adults. botox is also indicated for the treatment of dynamic equinus foot deformity due to spasticity in paediatric cerebral palsy patients two years of age or older. focal upper limb spasticity associated with stroke. botox is indicated also for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients aged 65 years or less. management of primary axillary hyperhidrosis in patients who failed other medical symptomatic treatment.symptom relief in adults fulfilling criteria for chronic migraine (headaches on ?15 days per month of which at least 8 days with migrai

בוטוקס 200 ישראל - עברית - Ministry of Health

בוטוקס 200

abbvie biopharmaceuticals ltd, israel - botulinum toxin type a - אבקה להכנת תמיסה לזריקה - botulinum toxin type a 200 u/vial - botulinum toxin - botulinum toxin - botox is indicated for the symptomatic relief of blepharospasm or vii nerve disorders in patients over 12 years hemifacial spasm and associated focal dystonias as well as the correction of strabismus in patients 12 years of age and above. botox is also indicated for the reduction of the signs and symptoms of spasmodic torticollis ( cervical dystonia) in adults. botox is also indicated for the treatment of dynamic equinus foot deformity due to spasticity in paediatric cerebral palsy patients two years of age or older. focal upper limb spasticity associated with stroke. botox is indicated also for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients aged 65 years or less.management of primary axillary hyperhidrosis in patients who failed other medical symptomatic treatment.symptom relief in adults fulfilling criteria for chronic migraine (headaches on ?15 days per month of which at least 8 days with migrain

מדיקינט MR כמוסות בשחרור מושהה 20 מ"ג ישראל - עברית - Ministry of Health

מדיקינט mr כמוסות בשחרור מושהה 20 מ"ג

mediline ltd. - methylphenidate hydrochloride 20 mg - modified release capsules - methylphenidate - medikinet modified release capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (adhd) in children over 6 years of age when remedial measures alone prove insufficient. treatment must be under the supervision of a specialist in childhood behavioural disorders. diagnosis should be made according to dsm-iv criteria or the guidelines in icd-10.

מודיקיט MR כמוסות בשחרור מושהה 30 מ"ג ישראל - עברית - Ministry of Health

מודיקיט mr כמוסות בשחרור מושהה 30 מ"ג

mediline ltd. - methylphenidate hydrochloride 30 mg - modified release capsules - methylphenidate - medikinet modified release capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (adhd) in children over 6 years of age when remedial measures alone prove insufficient.treatment must be under the supervision of a specialist in childhood behavioural disorders. diagnosis should be made according to dsm-iv criteria or the guidelines in icd-10.

מדיקינט MR כמוסות בשחרור מושהה 40 מ"ג ישראל - עברית - Ministry of Health

מדיקינט mr כמוסות בשחרור מושהה 40 מ"ג

mediline ltd. - methylphenidate hydrochloride 40 mg - modified release capsules - methylphenidate - medikinet modified release capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (adhd) in children over 6 years of age when remedial measures alone prove insufficient. treatment must be under the supervision of a specialist in childhood behavioural disorders. diagnosis should be made according to dsm-iv criteria or the guidelines in icd-10.

אביאקס פרמיקס % 5 וטרונרי ישראל - עברית - Ministry of Health

אביאקס פרמיקס % 5 וטרונרי

kofolk ltd - semduramicin 50 g/kg - powder - prevention of coccidiosis in broilers due to eimeria tenella, eimeiria acervu-ina, eimeiria brunetti, eimeiria necatrix, eimeiria mitavifmitis, eimeiria maxima. not to be administrated to laying hens during laying.

אלנקובן 200 וטרינרי ישראל - עברית - Ministry of Health

אלנקובן 200 וטרינרי

euromar ltd - monensin sodium 200 g/kg - premix - for the prevention of coccidiosis in broillers chickens for reproduction and turkeys - in food. elancoban in cattle (rumensin) is indicated for the prevention of coccidiosis caused by eimeria bovis and e.zuernii.

קלופידול 25 וטרינרי ישראל - עברית - Ministry of Health

קלופידול 25 וטרינרי

kofolk ltd - clopidol 255 g/kg - powder for solution - for the treatment of eimeria susceptible to clopidol in broilers .

אוואטק קדם תערובת % 15 וטרינרי ישראל - עברית - Ministry of Health

אוואטק קדם תערובת % 15 וטרינרי

a.bee-zee cons.& marketing ltd - lasalocid sodium 15 % - powder - medical additive for the prevention of coccidiosis in broilers and turkeys, cattle and sheep caused by various strains of eimeria.

קלופידול פלוס וטרינרי ישראל - עברית - Ministry of Health

קלופידול פלוס וטרינרי

phibro animal health ltd., israel - clopidol; methyl benzoquate - אבקה מסיסה - clopidol 20 %; methyl benzoquate 1.66 % - for prevention of eimeria susceptible to clopidol and methylbenzoquate in broilers.